1
|
Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
|
AIDS
|
1995
|
1.34
|
2
|
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.
|
J Med Primatol
|
1993
|
1.10
|
3
|
Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.
|
AIDS Res Hum Retroviruses
|
1994
|
1.00
|
4
|
Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.
|
J Exp Med
|
1994
|
0.98
|
5
|
The major polypeptides of the murine-mammary-tumor virus isolated by plant-lectin affinity chromatography.
|
Eur J Biochem
|
1977
|
0.97
|
6
|
Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees.
|
AIDS
|
2001
|
0.95
|
7
|
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.
|
J Virol
|
2000
|
0.93
|
8
|
Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS.
|
Immunol Lett
|
1996
|
0.92
|
9
|
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.
|
J Gen Virol
|
1995
|
0.92
|
10
|
Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
|
J Med Virol
|
2007
|
0.87
|
11
|
The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques.
|
J Gen Virol
|
2000
|
0.85
|
12
|
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
|
J Med Primatol
|
1992
|
0.83
|
13
|
Localization of murine mammary tumor virus polypeptides on the surface of tumor cells.
|
Eur J Cancer
|
1979
|
0.82
|
14
|
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines.
|
Vaccine
|
1994
|
0.79
|
15
|
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).
|
J Virol
|
2001
|
0.76
|
16
|
Lack of evidence for non-virion cell surface antigens on virally-induced murine mammary tumor cell.
|
Eur J Cancer
|
1980
|
0.75
|
17
|
The purification and characterization of a major glycoprotein of the murine mammary tumor virus.
|
Anal Biochem
|
1979
|
0.75
|
18
|
Expression of MuMTV antigens in rabbits and rats infected with MuMTV.
|
Virology
|
1979
|
0.75
|